Gaeumannomyces tritici strain:GGT-007
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA268052 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR1664730_1.fastq.gz | Fastqsanger.gz | |||
| SRR1664730_2.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 2 of 2 |
Similar Datasets
Project description:Gaeumannomyces graminis var. tritici R3-111a-1 transcriptome sequencing
| PRJNA52815 | ENA
Project description:The take-all disease caused by the soilborne fungus Gaeumannomyces graminis var tritici (Ggt) is one of the most-studied and widespread root diseases worldwide. Here, we investigated the ability of the earthworm Aporrectodea caliginosa to induce take-all disease tolerance in Triticum aestivum.
2013-06-01 | GSE47479 | GEO
Project description:Gaeumannomyces tritici strain:R3-111a-1 Genome sequencing and assembly
| PRJNA666297 | ENA
Project description:The take-all disease caused by the soilborne fungus Gaeumannomyces graminis var tritici (Ggt) is one of the most-studied and widespread root diseases worldwide. Here, we investigated the ability of the earthworm Aporrectodea caliginosa to induce take-all disease tolerance in Triticum aestivum. In a greenhouse experiment, plants were grown in a sandy soil. Plants were inoculated or not with Ggt and in the presence or absence of earthworms. There was 4 levels of treatment (plants only, inoculated with Ggt, inoculated with earthworms or inoculated with earthworms and Ggt), and 2-3 plants per treatments.
2013-06-01 | E-GEOD-47479 | biostudies-arrayexpress
Project description:A comparison of Chinese Spring wheat to infection by the pathogenic fungi Gaeumannomyces tritici and G. hyphopodioides (not known as a wheat pathogen) at three time points
2024-09-30 | GSE242417 | GEO
Project description:Z. tritici is a fungal pathogen causing the disease septoria tritici blotch, one of the most economically devastating foliar diseases in wheat. The molecular basis underlying Z. tritici growth, development and pathogenicity is not fully understood yet. Compared to the genomic investigations in this fungus, little is known about the protein expression at a systematic level. The aim of the project is to construct a comprehensive protein database of Z. tritici growing in nutrient-limiting and rich media and in vivo at a late stage of wheat infection by using 1D gel-based and SCX-based proteomics and subproteomics (intracellular and extracellular) approaches.
2018-07-05 | PXD002147 | Pride
Project description:Advanced-stage endometrial cancer patients typically receive a combination of platinum and paclitaxel chemotherapy. However, limited treatment options are available for those with recurrent disease, and there is a need to identify alternative treatment options for the advanced setting. Our goal was to evaluate the pre-clinical efficacy and mechanism of action of the anti-cancer drug Oklahoma Nitrone 007 (OKN-007) alone and in combination with carboplatin and paclitaxel in endometrial cancer. The effect of OKN-007 on the metabolic viability of endometrial cancer cells in both two- and three-dimensional (2D and 3D) cultures, as well as on clonogenic growth, in vitro was assessed. We also evaluated OKN-007 in vivo using an intraperitoneal xenograft model and targeted gene expression profiling to determine the molecular mechanism and gene expression programs altered by OKN-007. Our results showed that endometrial cancer cells were generally sensitive to OKN-007 in both 2D and 3D cultures. OKN-007 displayed a reduction in 3D spheroid and clonogenic growth. Subsequent targeted gene expression profiling revealed that OKN-007 significantly downregulated the immunosuppressive immunometabolic regulatory enzyme indolamine 2,3-dioxygenase 1 (IDO1) (-11.27-fold change) and modulated upstream inflammatory pathways that regulate IDO1 expression (interferon- (IFN-), Jak-STAT, TGF-β, and NF-kB), downstream IDO1 effector pathways (mTOR and aryl hydrocarbon receptor (AhR)) and altered T-cell co-signaling pathways. OKN-007 treatment reduced IDO1, SULF2, and TGF-β protein expression in vivo, and inhibited TGF-β, NF-kB, and AhR- receptor-mediated nuclear signaling in vitro. These findings indicate that OKN-007 surmounts pro-inflammatory, immunosuppressive, and pro-tumorigenic pathways and is a promising approach for the effective treat endometrial cancer. Targeted mRNA expression profiling was performed using the nCounter ® Tumor Signaling 360™ Panel (NanoString Technologies), which comprises 780 genes involved in cancer-related pathways and internal reference genes. Raw data were normalized and log2 transformed using the geNorm algorithm, differential expression (DE) was determined using the Generalized Linear Model (GLM), and Gene Set Analysis (GSA) was used to summarize the directed global significance score by calculating the change in regulation within each defined gene set relative to the baseline. Pathway enrichment was also calculated for gene sets as defined in multiple databases, including WikiPathways, REACTOME, MSigDB, and Gene Ontology, and FDR adjustment and p-Elim pruning scores were calculated when appropriate. DE, GSA, and other pathway enrichment were conducted using ROSALIND software (v. 3.38.5.1). Genes with >1.5-or <1.5-fold change at P < 0.05 were considered significantly differentially expressed.
2025-08-01 | GSE269693 | GEO
Project description:Bacillus subtilis strain:007 Genome sequencing
| PRJNA1253093 | ENA
Project description:The efficacy of killing human cancer cells by a modified Herpes-simplex-virus thymidine kinase TK.007/ganciclovir (GCV) system was investigated in malignant cells of different histogenetic origin. The aim was to determine whether different histogenetic origins of cancer cells in them-selves influence their reaction towards an approach of synthetic lethality, which theoretically should be applicable independently of the cell type. Fifteen malignant human cell lines were transduced with a lentiviral vector to stably express the TK.007 gene and cell proliferation assays under GCV were performed. Among TK.007-expressing cell lines, lymphoma and leuke-mia cells were more susceptible to killing than solid cancer cells, while osteosarcoma and mela-noma cells exhibited an intermediate susceptibility. Similar differences in killing were also noted in wild-type non-transduced cells. This study highlights that the histogenetic origin of malignant cells strongly influences their susceptibility towards cytotoxic agents, with leukemias and lym-phomas being more sensitive than solid cancer cells.
2025-01-17 | PXD052713 | Pride